Latest Market Leadership News

CAR Group has reported robust half-year results for FY25, showcasing strong revenue and earnings growth across its global markets, underpinned by strategic diversification and innovation.

DigitalX Limited has significantly increased its Solana holdings and reported robust fund performance for January 2025, capitalizing on favorable market and regulatory shifts.

REA Group has reported a robust half-year performance for H1 FY25, with revenue climbing 20% to $873 million and net profit surging 26%, driven by strong Australian and Indian market momentum and strategic technology investments.

REA Group has delivered a robust first half FY25 performance, posting a 20% revenue increase and a 26% rise in net profit, underpinned by strong Australian and Indian market growth. The company also announced a 26% higher interim dividend, signaling confidence in its ongoing momentum.

BluGlass Limited has secured over A$4 million in new contracts and filed three US patents for high-power tunable GaN lasers, reinforcing its leadership in visible laser technology and expanding its footprint in strategic photonics markets.

Simonds Group has agreed to acquire Dennis Family Homes for $10 million, significantly expanding its residential construction footprint and product portfolio across Victoria and New South Wales. The acquisition is expected to be earnings accretive from the first quarter of FY26.

Credit Corp Group reported steady H1 FY25 results with operational improvements and confirmed full-year guidance, driven by growth in US debt buying and stable Australian/New Zealand lending.

Acusensus has secured major contract expansions across Australia and New Zealand, driving a 15.8% revenue increase in Q2 FY25 and bolstering its cash reserves to $30.3 million. The company’s strategic international push and innovative enforcement technologies position it for sustained growth.

Redivium's Q2 FY25 report reveals strategic progress in lithium-ion battery recycling across Europe, including new partnerships and feasibility studies, while navigating tight cash reserves and a critical entitlement offer.

Microba Life Sciences reports a remarkable 102% revenue increase in Q2 FY25, driven by strong sales of its MetaXplore test in Australia and promising early traction in the UK. The company also advances its therapeutic pipeline with key clinical milestones.

XPON Technologies reports a modest 2% increase in martech revenue and a strong cash position for Q2 FY25, while navigating an 8% decline in annualised recurring revenue amid strategic sales recalibration.

Insignia Financial reported a robust 2.2% increase in Funds Under Management and Administration to $326.8 billion in 2Q25, underpinned by strong net inflows and strategic milestones including the IT separation from NAB and the unveiling of its Vision2030 growth strategy.